Lilly Looks To Take POINT On Emerging Cancer Radiopharmaceutical Space

 
• By Joseph Haas
Radioisotope
Lilly moves into radioligand therapy for cancer with buyout of Point • Source: Shutterstock

More from Deals

More from Business